MoneyWorks4Me

Dr Reddy's launches Fexofenadine HCl in US

15 Apr 2011 Evaluate

In a bid to tap $452 million Fexofenadine drug market, Dr Reddy's Laboratories has launched the generic version of Allegra (Fexofenadine HCl) tablets in the US market. The pharmaceutical firm will market the over-the-counter (OTC) product under store brand labels in the US market.  The products are bio equivalent versions of Sanofi-Aventis' Allegra tablets which received Rx-to-OTC switch approval from the FDA on January 24.crackcrack

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..